EGF/EGFR signaling triggered the release of EpEX from cell-surface EpCAM, after which the shed EpICD bound with EGFR to stabilize PD-L1 through the EGFR/ERK pathway in cancer cells (Fig. 2d) [6]. The gene discussed is EPCAM; the disease is cancer.